The Puerto Rico Science, Technology and Research Trust has awarded a $100,000 NIH SBIR Phase I Cash Match to LifeGene-Biomarks, Inc. to conduct research and development on the CervicalMethDx test under the project titled: Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas, funded by the National Institute for Minority Health and Disparities.
